Angelo Maria Minnella

Medicine & Life Sciences

1. Macular Degeneration 100%
2. Optical Coherence Tomography 82%
3. Visual Acuity 78%
4. Ranibizumab 51%
5. Eye 45%
6. Macular Degeneration, Age-Related, 2 43%
7. Crocus 40%
8. Complement Factor H 36%
9. Choroidal Neovascularization 34%
10. Macular Edema 34%
11. Diabetic Retinopathy 33%
12. Angiography 32%
13. Stargardt Disease 31%
14. Retina 27%
15. Cone-Rod Dystrophies 20%
16. Usher Syndromes 20%
17. Electroretinography 19%
18. Dexamethasone 18%
19. Type 1 Diabetes Mellitus 14%
20. Type 2A Usher syndrome 14%
21. Italy 14%
22. Intravitreal Injections 13%
23. Retinal Vein Occlusion 13%
24. Retinal Pigment Epithelium 13%
25. Retinal Vessels 13%
26. Retinal Dystrophies 12%
27. Enhanced S-Cone Syndrome 12%
28. Injections 11%
29. Gyrate Atrophy 11%
30. Camellia 11%
31. Porencephaly 11%
32. Angioid Streaks 10%
33. Fluocinolone Acetonide 10%
34. Vitelliform Macular Dystrophy 10%
35. Cryopyrin-Associated Periodic Syndromes 10%
36. Genotype 10%
37. Pseudoxanthoma Elasticum 10%
38. Safety 10%
39. Cidofovir 9%
40. Cardiovascular Diseases 9%
41. Inflammation 9%
42. Health Care Outcome Assessment 9%
43. Cataract 9%
44. Ophthalmology 9%
45. Therapeutics 9%
46. von Hippel-Lindau Disease 9%
47. Interleukin 1 Receptor Antagonist Protein 9%
48. Fabry Disease 9%
49. Ornithine 8%
50. Lighting 8%